Company Intelligence

Valence Discovery

Valence is unlocking the true potential of deep learning in drug design by unifying best-in-class deep learning technologies with intuitive infrastructure to allow any drug discovery team to become AI-enabled. We're proudly headquartered at Mila.

Official Website
In this profile

Quick Facts

  • Founded 2018
  • Headquarters Montréal, Americas
  • Country Americas
  • Industry AI in Enterprise Software
  • Company Type Techstars Montréal AI Accelerator
  • Status Acquired/Exited
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

Valence is unlocking the true potential of deep learning in drug design by unifying best-in-class deep learning technologies with intuitive infrastructure to allow any drug discovery team to become AI-enabled. We're proudly headquartered at Mila.

Why It Matters

Valence Discovery appears in the public Techstars Montréal AI Accelerator portfolio (open accelerator dataset).

Recent Developments

  1. Company status

    Documented status on Brel profile: Acquired/Exited.

    Source
  2. 2018 Company founded

    Valence Discovery was founded in 2018 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

AI in Enterprise Software Open industry

Valence is unlocking the true potential of deep learning in drug design by unifying best-in-class deep learning technologies with intuitive infrastructure to allow any drug discovery team to become AI-enabled. We’re proudly headquartered at Mila.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Request a correction if you represent this company or believe information is inaccurate.

Explore Related Intelligence

Products Product directory Founders Founder profiles Reports Open reports Industries Explore sectors

The AI Brief

Weekly company intelligence in your inbox.

Subscribe